JZ made the mistake of using his yahoo email as his linkedin / personal email for everything. Once some one found that out he was out of here.
2 out of the 3 SYN004 phase 2a sites haven't even started recruiting yet. There will obviously be a delay with that data. It's also too late to submit abstracts to any of the 2015 MS and Neurological national and international conferences That take place before July so that data is also oobviously going to be delayed.
What kind of slimy thing is management planning that they would change up their usual conference call schedule so that it lands right before the mou deadline? I'm guessing not even the connecting the dots guy would throw them softball questions like last time If it was held after the rejection.
Smart money dumping ahead of bad results. No other explanation. If Longs really believed this was worth a lot more then ask yourself, Why do they refuse to buy and why are there no other buyers.
No wonder institutions are dumping right now so it seems.
The maxim boiler room is currently pumping AVXL. I'm selling it around .40. A couple months ago they were pumping SYN, got out at 3 after riding it up from 2. Looking for their next pump and dump target at the moment.
Dodge all you want and don't address the facts that they don't own the rights for Alzheimer's. Still doesn't change it.
So that kirk and his cronies can sneak in and steal the company
2.60s now. That company has a lot of irrelevant news coming up that will be easy to fool 'unsophisticated' investors with.
I made money in the run-up when the oncs people were puming it. Sold last Friday. I think the ceo is pulling peoples leg with the Trimesta talk. Will probably rebuy at 1.60 for the next run-up.
Thats because they weren't funding trials by themselves last year like they are this year. It looks like the market agrees with me and not you.